CLEVELAND, Nov. 20, 2014 /PRNewswire/ – DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced that its Chairman and CEO, Mr. Laurence P. Birch, will present at the LD Micro Conference on December 3, 2014, at 5:30pm PST / 8:30pm EST, in Los Angeles.
“DATATRAK continues to transform the eClinical industry,” said Mr. Birch. “Our unified eClinical® solutions deliver differentiated benefits to the clinical trials industry, reinforced by our expanded and strengthened Data Unifier Patent Portfolio. DATATRAK reduces complexities, delivering time and cost savings and a superior user experience, all of which lead to better site compliance, better data, and ultimately a safer trial. And only DATATRAK offers the Unified Experience™ – and that’s great news for customers and investors alike.”
“We are honored to have DATATRAK International present at the Main Event this year,” stated Chris Lahiji, Founder of LD Micro.
The DATATRAK ONE® Unified Platform is the foundation of DATATRAK efficiencies, providing a single data source that powers all DATATRAK solutions, eliminating data integration. We offer industry-leading system reliability powered by the cloud, with an exceptional User Interface and a greater overall value.
Join DATATRAK Thought Leaders:
Tweet: DATATRAK #UnifiedExperience to be presented at LD Micro conference http://bit.ly/1thffzK
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK‘s Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina, Chicago, Illinois; and London, England. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s report filed with the OTCQX Market on November 13, 2014 announcing its results for the third quarter 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.